30 November 2020 | Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis
| Medina-Lara, A; Grigore, B; Lewis, R; et al. |
22 October 2018 | Conceptual modelling of the flow of frail elderly through acute-care hospitals: An evidence-based management approach
| Landa, P; Bruzzi, S; Tanfani, E; et al. |
21 January 2016 | Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention
| Panatto, D; Domnich, A; Gasparini, R; et al. |
27 April 2015 | A discrete event simulation model to support bed management
| Landa, Paolo; Sonnessa, Michele; Tànfani, Elena; et al. |
4 November 2016 | Economic evaluation of platelet-rich-plasma versus hyaluronic acid for the treatment of knee osteoarthritis. Scenarios to 1 and 5 years
| Landa, P; Landi, S; Russo, S |
17 October 2018 | A framework to address key issues of neonatal service configuration in England: the NeoNet multimethods study
| Villeneuve, E; Landa, P; Allen, M; et al. |
1 October 2017 | L’uso di modelli di simulazione per programmare, gestire e valutare i percorsi clinici ospedalieri
| Testi, A; Tanfani, E; Landa, P |
19 September 2018 | Methods for modelling the cost-effectiveness of interventions for prostate cancer: a systematic review - Protocol
| Snowsill, TM; Landa, P; Dethridge, B; et al. |
8 August 2022 | Revising the suspected-cancer guidelines: Impacts on patients’ primary care contacts and costs
| Price, S; Landa, P; Mujica-Mota, R; et al. |
22 October 2018 | Singing for People with Aphasia (SPA): A Protocol for a Pilot Randomised Controlled Trial of a Group Singing Intervention to Improve Wellbeing
| Tarrant, M; Carter, M; Dean, S; et al. |
13 January 2021 | Singing for people with aphasia (SPA): Results of a pilot feasibility randomised controlled trial of a group singing intervention investigating acceptability and feasibility
| Tarrant, M; Carter, M; Dean, SG; et al. |
10 May 2016 | Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
| Gasparini, R; Landa, P; Amicizia, D; et al. |